News coverage about Dynatronics (NASDAQ:DYNT) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Dynatronics earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 46.0587464711679 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Separately, Zacks Investment Research lowered Dynatronics from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th.

Dynatronics (NASDAQ:DYNT) opened at $2.66 on Thursday. Dynatronics has a 12 month low of $2.10 and a 12 month high of $3.75. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.46 and a quick ratio of 0.92.

Dynatronics (NASDAQ:DYNT) last issued its quarterly earnings results on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.08) by $0.08. Dynatronics had a negative return on equity of 45.78% and a negative net margin of 3.42%. The firm had revenue of $12.80 million for the quarter. equities research analysts anticipate that Dynatronics will post -0.09 EPS for the current year.

In other news, major shareholder Ventures 1 Lp Provco bought 300,000 shares of the stock in a transaction dated Thursday, November 30th. The shares were bought at an average cost of $2.50 per share, with a total value of $750,000.00. Following the completion of the transaction, the insider now directly owns 586,944 shares of the company’s stock, valued at $1,467,360. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Brian Larkin bought 40,000 shares of the stock in a transaction dated Thursday, November 30th. The shares were purchased at an average cost of $2.50 per share, for a total transaction of $100,000.00. Following the completion of the transaction, the director now directly owns 80,276 shares of the company’s stock, valued at $200,690. The disclosure for this purchase can be found here. 51.80% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Dynatronics (DYNT) Share Price” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this piece of content can be viewed at

Dynatronics Company Profile

Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.

Insider Buying and Selling by Quarter for Dynatronics (NASDAQ:DYNT)

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with's FREE daily email newsletter.